Revenue & Margin StrengthConsistent revenue growth coupled with robust gross and improving net margins reflects durable demand for Sigachi's MCC products and disciplined cost management. Sustained margin performance supports reinvestment in capacity and quality controls, bolstering long-term profitability and resilience across cycles.
Balance Sheet StabilityA healthy equity base and manageable leverage provide financial flexibility to fund strategic capex, absorb shocks and support supply continuity to pharma customers. Strong ROE indicates effective use of capital, underpinning the company's ability to pursue growth while maintaining credit access over the medium term.
Product Specialization (MCC)Deep specialization in microcrystalline cellulose creates high technical and regulatory barriers to entry, fostering sticky B2B relationships with pharmaceutical customers. Focused product expertise enables premium grading, repeat volumes and cross-sales into food and nutraceuticals, supporting steady structural demand.